PuriflOH (ASX: PO3) Share Price and News

Price

$0.22

Movement

( )

as at 18 Feb - Closed (20 mins delayed)

52 Week Range

-

 
1 Year Return

0.0

PuriflOH Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

$0.22

Day Change

( )

52 Week Range

-

Yesterday's Close

$0.22

Today's Open

Days Range

-

Volume

0

Avg. Volume (1 month)

0

Turnover

$0

as at 18 Feb - Closed

PuriflOH (ASX: PO3)
Latest News

rising asx share price represented by gold fish jumping out of water
Share Market News

Why the Purifloh (ASX:PO3) share price leapt 12% today

The company's shares are starting September off on a high note.

Read more »

pause in medical asx share price represented by doctor holding hand up in stop motion
Share Market News

Purifloh (ASX:PO3) shares enter trading halt after surging 24%

Purifloh enters a trading halt, what's going on?

Read more »

Happy investor looks at her computer to see the share price rise
Share Market News

ASX stock of the day: Purifloh (ASX:PO3) shares surge 22% on update

The Purifloh (ASX:PO3) share price is rocketing today, but why? Here's what investors are finding so exciting about this filtration…

Read more »

falling asx share price represented by child looking shocked at computer screen
52-Week Lows

Why the Purifloh (ASX:PO3) share price crashed to a 2-year low today

The Purifloh Ltd (ASX: PO3) share price tumbled to a near two-year low today after it announced the sudden resignation…

Read more »

a woman
Share Market News

PuriflOH share price soars 19% on OTC listing announcement

The PuriflOH share price has surged more than 19% for the day after receiving approval to list on the OTCQX,…

Read more »

PO3 ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
17th Feb 2025 2025-02-17T19:57:07 Confirmation of delistingYesNo7:57pm1120k
17th Feb 2025 2025-02-17T08:51:49 Removal from Official ListYesNo8:51am1116k
31st Jan 2025 2025-01-31T15:52:15 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo3:52pm81.1M
30th Jan 2025 2025-01-30T08:45:42 Proposed issue of securities - PO3YesNo8:45am827k
29th Jan 2025 2025-01-29T15:33:08 Notice of General Meeting/Proxy FormYesNo3:33pm741.1M
22nd Jan 2025 2025-01-22T16:20:01 Long Term Suspended EntitiesYesNo4:20pm8206k
29th Nov 2024 2024-11-29T13:31:45 2024 AGM - Results of meetingYesNo1:31pm2169k
29th Nov 2024 2024-11-29T13:31:30 2023 AGM - Results of meetingYesNo1:31pm2166k
6th Nov 2024 2024-11-06T12:02:11 Response to ASX QueryYesNo12:02pm12427k
31st Oct 2024 2024-10-31T14:28:36 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo2:28pm71.1M

About PuriflOH

Purifloh Ltd. engages in the provision of chemical free indoor air purification, water sanitation and surface sterilization solutions. The company was founded by Brian L. Harcourt on March 15, 2007 and is headquartered in South Melbourne, Australia.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Simon Richard Lill Non-Executive Director Mar 2024
Mr. Lill has a background of over 30 years of stockbroking, capital raising, management, business development and analysis for a range of small and start-up companies, in both the manufacturing and resources industries. He has assisted Mr. Le Souef in the restructuring of the Company in 2013 and has managed the Company's Australian affairs since that time. He has similarly assisted the restructure of De Grey Mining Limited from his appointment in 2013 and is now Chairman of that Company.
Dr Alex Sava Non-Executive Director Apr 2021
Dr Sava was the inventor of the aerosol hydrogen peroxide disinfection process ('nanonebulant'), that became a core technology of ASX200 company, Nanosonics Limited (NAN.ASX), Dr. Sava also has experience commercializing his inventions in numerous international markets. This has provided Dr Sava with strong regulatory and commercial experience which will be of specific relevance to the Company as it embarks on commercial execution.
Mr Carl Le Souef Non-Executive DirectorInterim Chairman Nov 2019
Mr.Le Souef is a founding partner and co-owner of Somnio Global. He oversaw the restructuring of PuriflOH (previously known as Water Resources Group Limited) during 2013/2014, which resulted in Dilato Holdings Pty Limited emerge as the major shareholder of PuriflOH, a position it still retains. Dilato Holdings is Mr. Le Souef's private investment company. Mr. Le Souef was previously the sole owner and CEO of one of Australia's largest privately owned FMCG organizations, Private Formula International, a global operation that included Australia's number one selling skincare range at the time, Dr LeWinn's Private Formula. In 2009, he negotiated the sale of the Company to a US based pharmaceutical major. Mr. Le Souef maintains an executive role in Somnio Global and in the management of his family office investments.
Mr Adam John Gallagher Company Secretary Mar 2024
-
Adam John Gallagher Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Dilato Holdings Pty Ltd 18,409,194 57.23%
Upjohn Laboratories Llc 5,271,601 16.39%
Andra M Rush 650,000 2.02%
Riveck Nominees Pty Ltd 487,000 1.51%
Flue Holdings Pty Ltd 306,000 0.95%
Gemtara Investments Pty Ltd 305,576 0.95%
Citicorp Nominees Pty Limited 289,167 0.90%
Anthony Mark Van Der Steeg 282,446 0.88%
Richard Li Ming Chan 260,000 0.81%
Arpitha Pradeep 250,000 0.78%
Targo Holdings Pty Ltd 245,250 0.76%
Birch & Associates Pty Ltd 236,262 0.73%
Steven Annear 224,278 0.70%
Malcolm Richmond 159,965 0.50%
HSBC Custody Nominees (Aus) Limited 148,786 0.46%
Isamg Pty Ltd 135,850 0.42%
Credal International Ltd 113,895 0.35%
Alexei Sava 100,000 0.31%
Ranchland Holdings Pty Ltd 100,000 0.31%
Jeremy Stone 93,429 0.29%
Saul Zaidman 86,050 0.27%

Profile

since

Note